AZD7507
- CAS No.
- 1041852-85-0
- Chemical Name:
- AZD7507
- Synonyms
- AZD7507;CS-2850;AZD7507, 10 mM in DMSO;AZD7507; AZD-7507; AZD 7507;1041852-85-0;4-(2-fluoro-4-methylanilino)-6-[4-(2-hydroxyethyl)piperazin-1-yl]-7-methoxycinnoline-3-carboxamide;3-Cinnolinecarboxamide, 4-[(2-fluoro-4-methylphenyl)amino]-6-[4-(2-hydroxyethyl)-1-piperazinyl]-7-methoxy-;AZD7507,AZD 7507,Inhibitor,AZD-7507,CSF-1R,CSF1R,CSF-1 receptor,c-Fms,inhibit,colony stimulating factor 1 receptor
- CBNumber:
- CB34804162
- Molecular Formula:
- C23H27FN6O3
- Molecular Weight:
- 454.5
- MDL Number:
- MOL File:
- 1041852-85-0.mol
- MSDS File:
- SDS
- TDS File:
- TDS
SAFETY
Risk and Safety Statements
| Symbol(GHS) | ![]() GHS07 |
|---|---|
| Signal word | Warning |
| Hazard statements | H302 |
| Precautionary statements | P264-P270-P301+P312-P330-P501 |
AZD7507 price
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Cayman Chemical | 37485 | AZD 7507 ≥98% | 1041852-85-0 | 1mg | $44 | 2026-04-30 | Buy |
| Cayman Chemical | 37485 | AZD 7507 ≥98% | 1041852-85-0 | 5mg | $198 | 2026-04-30 | Buy |
| Cayman Chemical | 37485 | AZD 7507 ≥98% | 1041852-85-0 | 10mg | $351 | 2026-04-30 | Buy |
| Cayman Chemical | 37485 | AZD 7507 ≥98% | 1041852-85-0 | 25mg | $767 | 2026-04-30 | Buy |
| Biosynth | RRB85285 | AZD7507 | 1041852-85-0 | 10mg | $1031.1 | 2026-06-05 | Buy |
AZD7507 Chemical Properties,Uses,Production
Uses
AZD7507 is a potent and orally active CSF-1R inhibitor, with antitumor activity.
in vivo
AZD7507 has good rat oral PK, with in vivo clearance of 7 mL/min/kg and 42% bioavailability. In the canine L-type Ca channel assay, the IC50 is >20 μM[1]. AZD7507 significantly decreases the number of CD68+ macrophages in mice, and also reduces the volume and mass in mice bearing CC-LP-1 and SNU-1079 cells, but not WITT-1 cells[2].
References
[1] Scott DA, et al. Mitigation of cardiovascular toxicity in a series of CSF-1R inhibitors, and the identification of AZD7507. Bioorg Med Chem Lett. 2013 Aug 15;23(16):4591-6. DOI:10.1016/j.bmcl.2013.06.031
[2] Boulter L, et al. WNT signaling drives cholangiocarcinoma growth and can be pharmacologically inhibited. Send to J Clin Invest. 2015 Mar 2;125(3):1269-85. DOI:10.1172/JCI76452
AZD7507 Preparation Products And Raw materials
Raw materials
Preparation Products
AZD7507 Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| ShangHai Caerulum Pharma Discovery Co., Ltd. | 18149758185 18149758185 | sales-cpd@caerulumpharma.com | China | 3493 | 58 |
| Sichuan Wei Keqi Biological Technology Co., Ltd. | 028-81700200 18116577057 | 3003855609@qq.com | China | 7717 | 56 |
| Shanghai Lollane Biological Technology Co.,Ltd. | 021-52996696,15000506266 15000506266 | China | 4861 | 55 | |
| Shanghai YuanYe Biotechnology Co., Ltd. | 15026964105 | 2881489226@qq.com | China | 89667 | 60 |
| Shanghai SuperLan Chemcial Technique Centre | 0-2022843681 15618226720 | chaolaichem@foxmail.com | China | 10000 | 58 |
| BOC Sciences | 16314854226; +8616314854226 | inquiry@bocsci.com | United States | 19852 | 58 |
| TargetMol Chemicals Inc. | +1-781-999-5354; +1-00000000000 | marketing@targetmol.com | United States | 32431 | 58 |
| InvivoChem | +1-708-310-1919 +1-13798911105 | sales@invivochem.cn | United States | 6378 | 58 |
| HANGZHOU CLAP TECHNOLOGY CO.,LTD | 86-571-88216897,88216896 13588875226 | sales@hzclap.com | CHINA | 6288 | 58 |
| Cckinase, Inc. | +1 (732)236-3202 | sales@cckinase.com | United States | 2728 | 58 |
1041852-85-0(AZD7507)Related Search:
1of2







